Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-13

FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lurasidone hydrochloride submitted by Accord Healthcare, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lurasidone hydrochloride (Lurasidone hydrochloride)

Snippet

SUPPL AP for LURASIDONE HYDROCHLORIDE (LURASIDONE HYDROCHLORIDE)